Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human bitter taste receptor (hBTR) refers to a family of approximately 25 G protein-coupled receptors (GPCRs) known as the TAS2R family. Primarily located on the tongue's taste buds, these receptors detect a wide variety of bitter-tasting compounds, serving as a biological warning system against the ingestion of potentially toxic substances. Beyond the oral cavity, hBTRs are expressed in diverse tissues including the respiratory tract, gastrointestinal system, and immune cells, where they play roles in bronchodilation, gut hormone release, and pathogen sensing. In the context of drug development, hBTRs are significant both as targets for treating respiratory diseases like asthma and as factors influencing drug compliance due to the bitter taste of many pharmaceutical agents. Research into hBTRs involves identifying specific agonists and antagonists to modulate taste perception or therapeutic pathways in extra-oral tissues.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human bitter taste receptor (hBTR).